Objectives: Levodopa-carbidopa intestinal gel (LCIG) was developed to reduce motor complications in Parkinson’s disease (PD) caused by pulsatile levodopa plasma concentrations following oral levodopa administration. Dyskinesia and ‘wearing off’ symptoms can vary between Asian and Caucasian patients with PD, thus highlighting the importance of assessing the effectiveness of LCIG in an Asian population. Efficacy and safety of LCIG were previously assessed in a 12-week open-label study; we report the efficacy and safety of at least 52 weeks of LCIG treatment in Japanese, Taiwanese, and Korean patients with advanced PD in the ongoing extension study. Methods: In this interim analysis of a phase III, open-label, multicenter extension study in Ja...
Motor complications in Parkinson's disease (PD) are associated with long-term oral levodopa treatmen...
Background: Levodopa-carbidopa intestinal gel (LCIG; carbidopa-levodopa enteral suspension in the Un...
Introduction: Levodopa/carbidopa intestinal gel (LCIG; carbidopa/levodopa enteral suspension) has be...
Introduction: The GLORIA registry included 375 advanced Parkinson’s disease (PD) patients and evalua...
© 2017, Media Sphera. All rights reserved.Objective: To evaluate the long-term safety and efficacy o...
© 2017, Media Sphera. All rights reserved.Objective: To evaluate the long-term safety and efficacy o...
Introduction: This registry evaluated the 24-month safety and efficacy of levodopa-carbidopa intesti...
INTRODUCTION: This registry evaluated the 24-month safety and efficacy of levodopa-carbidopa intesti...
Background: Levodopa-carbidopa intestinal gel (LCIG) is delivered continuously via intrajejunal perc...
INTRODUCTION: This registry evaluated the 24-month safety and efficacy of levodopa-carbidopa intesti...
Background. Levodopa-carbidopa intestinal gel (LCIG) provides continuous levodopa administration and...
Introduction This registry evaluated the 24-month safety and efficacy of levodopa-carbidopa intestin...
Introduction: Levodopa/carbidopa intestinal gel (LCIG; carbidopa/levodopa enteral suspension) has be...
Introduction: Parkinson’s disease in its advanced stage is a progressive condition that can be treat...
Introduction: Levodopa/carbidopa intestinal gel (LCIG; carbidopa/levodopa enteral suspension) has be...
Motor complications in Parkinson's disease (PD) are associated with long-term oral levodopa treatmen...
Background: Levodopa-carbidopa intestinal gel (LCIG; carbidopa-levodopa enteral suspension in the Un...
Introduction: Levodopa/carbidopa intestinal gel (LCIG; carbidopa/levodopa enteral suspension) has be...
Introduction: The GLORIA registry included 375 advanced Parkinson’s disease (PD) patients and evalua...
© 2017, Media Sphera. All rights reserved.Objective: To evaluate the long-term safety and efficacy o...
© 2017, Media Sphera. All rights reserved.Objective: To evaluate the long-term safety and efficacy o...
Introduction: This registry evaluated the 24-month safety and efficacy of levodopa-carbidopa intesti...
INTRODUCTION: This registry evaluated the 24-month safety and efficacy of levodopa-carbidopa intesti...
Background: Levodopa-carbidopa intestinal gel (LCIG) is delivered continuously via intrajejunal perc...
INTRODUCTION: This registry evaluated the 24-month safety and efficacy of levodopa-carbidopa intesti...
Background. Levodopa-carbidopa intestinal gel (LCIG) provides continuous levodopa administration and...
Introduction This registry evaluated the 24-month safety and efficacy of levodopa-carbidopa intestin...
Introduction: Levodopa/carbidopa intestinal gel (LCIG; carbidopa/levodopa enteral suspension) has be...
Introduction: Parkinson’s disease in its advanced stage is a progressive condition that can be treat...
Introduction: Levodopa/carbidopa intestinal gel (LCIG; carbidopa/levodopa enteral suspension) has be...
Motor complications in Parkinson's disease (PD) are associated with long-term oral levodopa treatmen...
Background: Levodopa-carbidopa intestinal gel (LCIG; carbidopa-levodopa enteral suspension in the Un...
Introduction: Levodopa/carbidopa intestinal gel (LCIG; carbidopa/levodopa enteral suspension) has be...